Cargando…

Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis

OBJECTIVES: To determine the cost-effectiveness of the addition of chromosomal anomalies detectable by non-invasive prenatal screening (NIPS), in a prenatal screening programme targeting common aneuploidies. DESIGN, SETTING AND PARTICIPANTS: A simulation study was conducted to study the addition of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soukkhaphone, Bounhome, Baradaran, Mohammad, Nguyen, Ba Diep, Nshimyumukiza, Leon, Little, Julian, Rousseau, Francois, Audibert, Francois, Langlois, Sylvie, Reinharz, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471875/ https://www.ncbi.nlm.nih.gov/pubmed/37648381 http://dx.doi.org/10.1136/bmjopen-2022-069485

Ejemplares similares

Non‐invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta‐analysis of diagnostic test accuracy studies
por: Soukkhaphone, Bounhome, et al.
Publicado: (2021)

Development of a discrete choice experiment questionnaire to elicit preferences by pregnant women and policymakers for the expansion of non-invasive prenatal screening
por: Nguyen, Hung Manh, et al.
Publicado: (2023)

Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study
por: Nguyen, Hung Manh, et al.
Publicado: (2023)

Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues
por: Gekas, Jean, et al.
Publicado: (2016)

Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis
por: Nshimyumukiza, L., et al.
Publicado: (2020)

Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation
por: Gekas, Jean, et al.
Publicado: (2009)

An Analytical Mobile App for Shared Decision Making About Prenatal Screening: Protocol for a Mixed Methods Study
por: Abbasgholizadeh Rahimi, Samira, et al.
Publicado: (2019)

Prenatal screening of cytogenetic anomalies – a Western Indian experience
por: Sheth, Frenny, et al.
Publicado: (2015)

An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
por: Nshimyumukiza, Léon, et al.
Publicado: (2013)

Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities
por: Gekas, Jean, et al.
Publicado: (2011)

Regulation and financing of prenatal screening and diagnostic tests for fetal anomalies in Europe
por: Reinsperger, I, et al.
Publicado: (2022)

Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma
por: Gekas, Jean, et al.
Publicado: (2014)

Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model
por: Nshimyumukiza, Léon, et al.
Publicado: (2013)

Prenatal ultrasound screening and congenital anomalies at birth by region: Pattern and distribution in Latvia
por: Zile-Velika, Irisa, et al.
Publicado: (2023)

Repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK: a cost-effectiveness analysis
por: Huntington, Susie, et al.
Publicado: (2020)

Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study
por: Rousseau, François, et al.
Publicado: (2019)

Prenatal screening for congenital anomalies: exploring midwives’ perceptions of counseling clients with religious backgrounds
por: Gitsels–van der Wal, Janneke T, et al.
Publicado: (2014)

Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome
por: Boyd, PA, et al.
Publicado: (2008)

Effect of prenatal screening on trends in perinatal mortality associated with congenital anomalies before and after the introduction of prenatal screening: A population‐based study in the Northern Netherlands
por: Bardi, Francesca, et al.
Publicado: (2021)

Women’s worries about prenatal screening tests suspected of fetal anomalies: a qualitative study
por: Mirtabar, Seyyedeh Mahboubeh, et al.
Publicado: (2023)

Sociodemographic Differences in Prenatal Diagnosis of Chromosomal Anomalies: A Population-Based Study
por: Santoro, Michele, et al.
Publicado: (2021)

The importance of rapid aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities
por: Elsayed, Ghada M, et al.
Publicado: (2013)

Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results
por: Zhou, Qin, et al.
Publicado: (2021)

Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening
por: Metcalfe, Amy, et al.
Publicado: (2014)

Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study
por: Gitsels - van der Wal, Janneke T, et al.
Publicado: (2014)

Epidemiology of Multiple Congenital Anomalies Before and After Implementation of a Nationwide Prenatal Screening Program in Denmark
por: Toxværd, Marlene E., et al.
Publicado: (2021)

Organised screening for cervical cancer in France: a cost-effectiveness assessment
por: Barré, Stéphanie, et al.
Publicado: (2017)

What factors influence health professionals to use decision aids for Down syndrome prenatal screening?
por: Lépine, Johanie, et al.
Publicado: (2016)

Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis
por: Sun, Lijuan, et al.
Publicado: (2015)

The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study
por: Yuan, Xiying, et al.
Publicado: (2023)

Prenatal Screening for Chromosomal Abnormalities: Where do We Stand Today in Mediterranean Countries?
por: Rizos, Demetrios
Publicado: (2018)

Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood
por: Zhang, Bin, et al.
Publicado: (2017)

Performance of non-invasive prenatal screening for sex chromosome aneuploidies and parental decision-making
por: Song, Jie-Ping, et al.
Publicado: (2020)

Synthesis of positive plasmas with known chromosomal abnormalities for validation of non-invasive prenatal screening
por: Qi, Zhongxia, et al.
Publicado: (2023)

Association between chromosome abnormities and prenatal diagnosis indicators screening in the second trimester of pregnancy
por: Pan, Ci, et al.
Publicado: (2023)

User Experience of a Computer-Based Decision Aid for Prenatal Trisomy Screening: Mixed Methods Explanatory Study
por: Agbadje, Titilayo Tatiana, et al.
Publicado: (2022)

Cost‐effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point‐of‐care rapid test versus clinical judgment
por: Nshimyumukiza, Léon, et al.
Publicado: (2016)

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua
por: Campos, Nicole G, et al.
Publicado: (2017)

Budget impact analysis of a home-based colorectal cancer screening programme in Malaysia
por: Ngan, Tran Thu, et al.
Publicado: (2023)

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis
por: Binquet, Christine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rtfo9b5iqbdgvr851hdbae5tsv